Host or pathogen-related factors in COVID-19 severity? – Authors' reply
暂无分享,去创建一个
S. Bhatt | S. Flaxman | Swapnil Mishra | A. Gandy | C. Whittaker | R. Verity | E. Volz | O. Watson | P. Walker | A. Ghani | C. Donnelly | S. Riley | L. Okell | N. Ferguson | A. Katzourakis
[1] D. A. Jackson,et al. Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity , 2020, Cell.
[2] Sebastian Maurer-Stroh,et al. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study , 2020, The Lancet.
[3] Jennifer L. Bell,et al. Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report , 2020, medRxiv.
[4] M. Farzan,et al. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity , 2020, bioRxiv.
[5] S. Bhatt,et al. Have deaths from COVID-19 in Europe plateaued due to herd immunity? , 2020, The Lancet.
[6] C. Gortázar,et al. COVID-19 severity declines over time , 2020 .
[7] Yoon-Seok Chung,et al. Genome-Wide Identification and Characterization of Point Mutations in the SARS-CoV-2 Genome , 2020, Osong public health and research perspectives.